
10,000+ employees
Founded 2010
𧬠Biotechnology
π₯ Healthcare
π Pharmaceuticals
Biotechnology β’ Healthcare β’ Pharmaceuticals
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting the development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.
π October 8
π United States, Switzerland β Remote
π΅ $153.1k - $203.1k / year
β° Full Time
π Senior
π Director
π» Ghost score 1%
Where this job comes from
Posted on BeOne Medicines's careers page β, not through a job board
First seen by Remote Rocketship October 8
Still open on BeOne Medicines's site. Checked 6 hours ago.

10,000+ employees
Founded 2010
𧬠Biotechnology
π₯ Healthcare
π Pharmaceuticals
Biotechnology β’ Healthcare β’ Pharmaceuticals
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting the development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.
β’ Drive global value, access, pricing, and reimbursement launch-readiness for an assigned asset across geographies β’ Translate pivotal evidence and the competitive landscape into differentiated global access and pricing tactics β’ Develop country-ready toolkits enabling local affiliates to secure timely reimbursement and optimal patient access β’ Coordinate with Hematology portfolio leads whose assets share similar indications β’ Collaborate with HEOR, Medical, Commercial, Clinical Development, Regulatory, Pricing, Medical Affairs, and affiliate teams β’ Develop and help lead global market access and reimbursement strategies across lead and future pipeline indications β’ Provide GVAP input to lifecycle planning, indication sequencing, evidence prioritization, governance, and oversight β’ Translate payer insights into recommendations for clinical development, evidence generation, pricing, access strategy, and commercialization planning β’ Integrate access and payer requirements into development processes, including trial design, endpoints, and evidence generation β’ Build global value dossiers, budget-impact and cost-effectiveness frameworks, and payer communication materials β’ Support EU Joint Clinical Assessment strategy and dossier development β’ Track access milestones, evidence needs, and deliverables against launch plans; flag risks and dependencies β’ Serve as day-to-day contact for regional and affiliate teams on access and pricing deliverables β’ Train teams on access toolkits and share materials β’ Monitor competitive, pricing, HTA, and policy landscapes, including BTK-class dynamics and EU HTA/JCA developments β’ Report affiliate and payer insights to the Director
β’ Undergraduate science degree required β’ Bachelor's degree in life sciences, health economics, pharmacy, health policy, business, or a related field β’ 8+ years of biopharmaceutical experience, with a substantial portion in global, regional, or country value, access, pricing, and reimbursement roles β’ Demonstrated expertise in HTA processes and payer systems across key markets, including G-BA/IQWiG, NICE, and HAS β’ Knowledge of the US payer environment; IRA/MFN awareness is a plus β’ Experience building global value dossiers, HTA/EU HTA JCA submission content, and payer value evidence in partnership with HEOR β’ Working knowledge of global or major-market pricing strategy, IRP/reference-pricing management, and price/revenue scenario modelling for specialty or oncology/hematology products β’ Strong understanding of pivotal-trial evidence interpretation and comparator/competitive assessment in oncology or hematology β’ Proven ability to lead cross-functional and cross-regional initiatives and influence without direct authority in a matrixed, global organisation β’ Excellent written and verbal communication skills in English β’ International travel expected β’ Advanced degree (MSc, MPH, PharmD, PhD, or MBA) strongly preferred β’ In-country, regional, or affiliate market access, pricing, reimbursement, or HTA experience preferred β’ Launch experience in oncology/hematology, ideally including EU JCA launches, preferred β’ HEOR fluency in budget-impact and cost-effectiveness modelling preferred
β’ Annual bonus plan for Non-Commercial roles β’ Incentive compensation plan for Commercial roles β’ Discretionary equity awards β’ Employee Stock Purchase Plan β’ Medical insurance β’ Dental insurance β’ Vision insurance β’ 401(k) β’ FSA/HSA β’ Life Insurance β’ Paid Time Off β’ Wellness benefits β’ International travel support
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π October 8
Director leading Amgenβs U.S. pharmaceutical copay and patient affordability programs. Managing strategy, operations, financial performance, vendors, and cross-functional teams.
πΊπΈ United States β Remote
π΅ $199.4k - $269.8k / year
π° $28.5G Post-IPO Debt on 2022-12
β° Full Time
π Senior
π΄ Lead
π Director
π¦ H1B Visa Sponsor
π October 8
Capture Director leading Medicaid proposal strategy, competitive intelligence, and capture planning for CVS Healthβs Aetna business. Remote role supporting new markets and health plan reprocurement.
π October 8
University of Rochester director leading enterprise medical credentialing, privileging, and accreditation. Overseeing regulatory compliance, audits, practitioner files, and Medical Staff Services teams.
πΊπΈ United States β Remote
π΅ $109k - $163.6k / year
β° Full Time
π Senior
π΄ Lead
π Director
π October 8
Breast oncology lifecycle leader shaping commercial strategy for Nateraβs cfDNA diagnostics. Driving evidence planning, market access, KOL engagement, and Signatera adoption.
πΊπΈ United States β Remote
π΅ $153.9k - $233.3k / year
β° Full Time
π Senior
π΄ Lead
π Director
π¦ H1B Visa Sponsor
π October 8
Clinical Science Director advancing Exelixis oncology drug development studies. Designing trials, authoring protocols, interpreting data, and supporting regulatory submissions.
πΊπΈ United States β Remote
π΅ $195k - $277.5k / year
π° $65M Post-IPO Equity on 2012-02
β° Full Time
π Senior
π Director
π¦ H1B Visa Sponsor